Meeting News

Study finds pathway for UVB light exposure as trigger for flares in SLE

November 25, 2019
ATLANTA — Upregulation of the cGAS-STING pathway may be implicated in disease flares of systemic lupus erythematosus that are triggered by…
Meeting NewsVideo

VIDEO: Ronald M. Laxer, MDCM, FRCPC, addresses rheumatologic disease 'masquerading' as infection

November 24, 2019
NEW YORK — Certain rheumatologic diseases can often appear initially to be infections, according to Ronald M. Laxer, MDCM, FRCPC, professor…
Meeting News

Lupus Foundation of America encourages patient self-management

November 22, 2019
ATLANTA — The Lupus Foundation of America conducted two studies that aimed to help patients feel empowered and motivated to self-manage their…
Meeting News

Romosozumab increases bone density across varying levels of renal function

November 22, 2019
ATLANTA — Romosozumab increases bone mineral density among patients with osteoporosis across different levels of renal function, according to a…
Meeting News

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset

November 22, 2019
ATLANTA — The presence of tenosynovitis, along with an anti-filaggrin peptide, were associated with the development of rheumatoid arthritis in…
Meeting News

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue

November 22, 2019
ATLANTA — Although disease flares were common among patients with rheumatoid arthritis who received immune checkpoint inhibitors to treat…
Meeting News

Multibiomarker disease activity test predicts radiographic progression, CV outcomes in RA

November 21, 2019
ATLANTA — A multibiomarker disease activity blood test predicted radiographic progression and cardiovascular outcomes in patients with…
Meeting News

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA

November 21, 2019
ATLANTA — Biologic DMARDs were as efficacious among patients with rheumatoid arthritis aged 60 years and older at disease onset as it was among…
Meeting News

Ixekizumab plus background drugs bested background drugs alone in axial SpA

November 21, 2019
ATLANTA — Ixekizumab combined with conventional background medication is superior to both conventional background medication alone and placebo…
Meeting News

Intervention bundle improves flu vaccination rates in RA/JIA patients

November 21, 2019
ATLANTA — An intervention bundle reminding patients with rheumatoid arthritis and juvenile idiopathic arthritis of the benefits of influenza…
Meeting News

Experts create algorithm for management of cutaneous manifestations in lupus

November 20, 2019
Researchers compiled a treatment algorithm for cutaneous manifestations of lupus erythematosus based on data from 104 studies, according to a study…
Meeting News

Upadacitinib improves signs, symptoms in patients with active AS

November 20, 2019
ATLANTA — A daily regimen of 15 mg upadacitinib was significantly more effective than placebo in improving signs, symptoms, function and…
In the Journals

PsA diagnosis often delayed in dermatology vs. rheumatology

November 20, 2019
In the dermatology setting, researchers found a substantial delay from symptom onset to a psoriatic arthritis diagnosis compared with rheumatology…

ACR adds Vectra test to recommended RA activity measures

November 20, 2019
The American College of Rheumatology has added the Vectra blood test, developed by Myriad Genetics, to its list of recommended disease activity…
Meeting News

Mitochondrial abnormalities a prognostic marker for juvenile dermatomyositis

November 20, 2019
ATLANTA — Patients with juvenile dermatomyositis demonstrate obvious mitochondrial abnormalities in the tissue and periphery, supporting the…
Feature

Physicians tapering patients off opioids can turn to HHS guide

November 20, 2019
A recent study suggests that less than a quarter of patients on chronic opioid therapy for noncancer pain are tapered off opioids, and another study…
Meeting News

Common rheumatologic drugs may impede checkpoint inhibitor efficacy

November 20, 2019
ATLANTA — Drugs that have known potential impacts on gut microbiota and are commonly prescribed by rheumatologists can have detrimental impacts…
Meeting News

Maternal use of non-TNF inhibitor biologic, tofacitinib pose minimal infectious risk to offspring

November 19, 2019
ATLANTA — The use of either non-TNF inhibitor biologics or tofacitinib for chronic inflammatory diseases during pregnancy did not significantly…
Meeting News

Tofacitinib bested placebo for disease flares in polyarticular JIA

November 19, 2019
ATLANTA — Results of a double-blind, randomized, placebo-controlled trial showed a clear benefit of tofacitinib in controlling disease flares…
Meeting News

Children with Down syndrome have higher risk for arthritis, delayed diagnosis

November 19, 2019
ATLANTA — Children with Down syndrome are at an increased risk for arthritis at a rate that is two to three times higher than previously…